The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using circular dichroism spectra to estimate protein secondary structure
Greenfield, N. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.202 · Cited by 4,014
How to measure and predict the molar absorption coefficient of a protein
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., & Gray, T. (1995) · Protein Science · doi:10.1002/pro.5560041120 · Cited by 3,907
(1987) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(87)90411-7 · Cited by 2,958
Stability of Proteins Small Globular Proteins
Privalov, P. L. (1979) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60460-x · Cited by 2,159
High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery
Pantoliano, M. W., Petrella, E. C., Kwasnoski, J. D., Lobanov, V. S., Myslik, J., Graf, E., Carver, T., Asel, E., Springer, B. A., Lane, P., et al. (2001) · SLAS Discovery · doi:10.1177/108705710100600609 · Cited by 893
Thermofluor-based high-throughput stability optimization of proteins for structural studies
Ericsson, U. B., Hallberg, B. M., DeTitta, G. T., Dekker, N., & Nordlund, P. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.07.027 · Cited by 839
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery
Lo, M.-C., Aulabaugh, A., Jin, G., Cowling, R., Bard, J., Malamas, M., & Ellestad, G. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.04.031 · Cited by 684
Vedadi, M., Niesen, F. H., Allali-Hassani, A., Fedorov, O. Y., Finerty, P. J., Wasney, G. A., Yeung, R., Arrowsmith, C., Ball, L. J., Berglund, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605224103 · Cited by 589
Self-citationData for Biochemical Research (third edition)
Wood, E. (1987) · Biochemical Education · doi:10.1016/0307-4412(87)90110-5 · Cited by 518
Matulis, D., Kranz, J. K., Salemme, F. R., & Todd, M. J. (2005) · Biochemistry · doi:10.1021/bi048135v · Cited by 495
Cited by
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Corrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560
The cellular thermal shift assay for evaluating drug target interactions in cells
Jafari, R., Almqvist, H., Axelsson, H., Ignatushchenko, M., Lundbäck, T., Nordlund, P., & Molina, D. M. (2014) · Nature Protocols · doi:10.1038/nprot.2014.138 · Cited by 1,474
Protein production and purification
Structural Genomics Consortium, Biologiques, A. E. F. D. M., Berkeley Structural Genomics Center, China Structural Genomics Consortium, Integrated Center for Structure and Function Innovation, Israel Structural Proteomics Center, Joint Center for Structural Genomics, Midwest Center for Structural Genomics, New York Structural GenomiX Research Center for Structural Genomics, Northeast Structural Genomics Consortium, et al. (2008) · Nature Methods · doi:10.1038/nmeth.f.202 · Cited by 916
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0327-9 · Cited by 707
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Lito, P., Solomon, M., Li, L.-S., Hansen, R., & Rosen, N. (2016) · Science · doi:10.1126/science.aad6204 · Cited by 691
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Huang, Y., Yan, J., Li, Q., Li, J., Gong, S., Zhou, H., Gan, J., Jiang, H., Jia, G.-F., Luo, C., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1276 · Cited by 662
Ghorashian, S., Kramer, A. M., Onuoha, S., Wright, G., Bartram, J., Richardson, R., Albon, S. J., Casanovas-Company, J., Castro, F., Popova, B., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0549-5 · Cited by 632
Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage
Jiang, F., Taylor, D. W., Chen, J. S., Kornfeld, J. E., Zhou, K., Thompson, A. J., Nogales, E., & Doudna, J. A. (2016) · Science · doi:10.1126/science.aad8282 · Cited by 624
Hamiaux, C., Drummond, R. S. M., Janssen, B. J., Ledger, S. E., Cooney, J. M., Newcomb, R. D., & Snowden, K. C. (2012) · Current Biology · doi:10.1016/j.cub.2012.08.007 · Cited by 623
Analysis of Protein Stability and Ligand Interactions by Thermal Shift Assay
Huynh, K., & Partch, C. L. (2015) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps2809s79 · Cited by 575
Bommarius, A. S., & Paye, M. F. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60137d · Cited by 493
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460
Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway
Saxton, R. A., Knockenhauer, K. E., Wolfson, R. L., Chantranupong, L., Pacold, M. E., Wang, T., Schwartz, T. U., & Sabatini, D. M. (2016) · Science · doi:10.1126/science.aad2087 · Cited by 457
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
Wahlberg, E., Karlberg, T., Kouznetsova, E., Markova, N., Macchiarulo, A., Thorsell, A.-G., Pol, E., Frostell, Å., Ekblad, T., Öncü, D., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2121 · Cited by 457
Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
Chen, B., Ye, F., Yu, L., Jia, G., Huang, X., Zhang, X., Peng, S., Chen, K., Wang, M., Gong, S., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3064149 · Cited by 444
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
Zak, K. M., Grudnik, P., Guzik, K., Zieba, B. J., Musielak, B., Dömling, A., Dubin, G., & Holak, T. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8730 · Cited by 422
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Xiang, Y., Nambulli, S., Xiao, Z., Liu, H., Sang, Z., Duprex, W. P., Schneidman-Duhovny, D., Zhang, C., & Shi, Y. (2020) · Science · doi:10.1126/science.abe4747 · Cited by 416
Liberato, M. V., Nascimento, A. S., Ayers, S. D., Lin, J. Z., Cvoro, A., Silveira, R. L., Martínez, L., Souza, P. C. T., Saidemberg, D., Deng, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036297 · Cited by 411
Deng, X., Hackbart, M., Mettelman, R. C., O’Brien, A., Mielech, A. M., Yi, G., Kao, C. C., & Baker, S. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618310114 · Cited by 386
An artificial metalloenzyme with the kinetics of native enzymes
Dydio, P., Key, H. M., Nazarenko, A., Rha, J. Y.-E., Seyedkazemi, V., Clark, D. S., & Hartwig, J. F. (2016) · Science · doi:10.1126/science.aah4427 · Cited by 384
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
Targeting a neoantigen derived from a common TP53 mutation
Hsiue, E. H.-C., Wright, K. M., Douglass, J., Hwang, M. S., Mog, B. J., Pearlman, A. H., Paul, S., DiNapoli, S. R., Konig, M. F., Wang, Q., et al. (2021) · Science · doi:10.1126/science.abc8697 · Cited by 367
The impact of glycosylation on monoclonal antibody conformation and stability
Zheng, K., Bantog, C., & Bayer, R. (2011) · mAbs · doi:10.4161/mabs.3.6.17922 · Cited by 342
Recent progress in multienzymes co-immobilization and multienzyme system applications
Ren, S., Li, C., Jiao, X., Jia, S., Jiang, Y., Bilal, M., & Cui, J. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.05.141 · Cited by 342
WD40 repeat domain proteins: a novel target class?
Schapira, M., Tyers, M., Torrent, M., & Arrowsmith, C. H. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.179 · Cited by 335
Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
Wu, W.-I., Voegtli, W. C., Sturgis, H. L., Dizon, F. P., Vigers, G. P. A., & Brandhuber, B. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012913 · Cited by 331
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
Roig-Zamboni, V., Cobucci-Ponzano, B., Iacono, R., Ferrara, M. C., Germany, S., Bourne, Y., Parenti, G., Moracci, M., & Sulzenbacher, G. (2017) · Nature Communications · doi:10.1038/s41467-017-01263-3 · Cited by 317
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., & Skehel, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807142105 · Cited by 314
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Rumpf, T., Schiedel, M., Karaman, B., Roessler, C., North, B. J., Lehotzky, A., Oláh, J., Ladwein, K. I., Schmidtkunz, K., Gajer, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7263 · Cited by 297
Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution
Gaetani, M., Sabatier, P., Saei, A. A., Beusch, C. M., Yang, Z., Lundström, S. L., & Zubarev, R. A. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00500 · Cited by 287
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
Grebien, F., Vedadi, M., Getlik, M., Giambruno, R., Grover, A., Avellino, R., Skucha, A., Vittori, S., Kuznetsova, E., Smil, D., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1859 · Cited by 284
Self-citationRabeh, W. M., Bossard, F., Xu, H., Okiyoneda, T., Bagdany, M., Mulvihill, C. M., Du, K., di Bernardo, S., Liu, Y., Konermann, L., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.024 · Cited by 280
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
Athuluri-Divakar, S. K., Vasquez-Del Carpio, R., Dutta, K., Baker, S. J., Cosenza, S. C., Basu, I., Gupta, Y. K., Reddy, M. V. R., Ueno, L., Hart, J. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.045 · Cited by 277
Importazole, a Small Molecule Inhibitor of the Transport Receptor Importin-β
Soderholm, J. F., Bird, S. L., Kalab, P., Sampathkumar, Y., Hasegawa, K., Uehara-Bingen, M., Weis, K., & Heald, R. (2011) · ACS Chemical Biology · doi:10.1021/cb2000296 · Cited by 274
Yi, G., Brendel, V. P., Shu, C., Li, P., Palanathan, S., & Cheng Kao, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077846 · Cited by 270
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Theory and applications of differential scanning fluorimetry in early-stage drug discovery
Gao, K., Oerlemans, R., & Groves, M. R. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00619-2 · Cited by 263
Fukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 260
Kober, D. L., Alexander-Brett, J. M., Karch, C. M., Cruchaga, C., Colonna, M., Holtzman, M. J., & Brett, T. J. (2016) · eLife · doi:10.7554/elife.20391 · Cited by 238
The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
He, Y., Selvaraju, S., Curtin, M. L., Jakob, C. G., Zhu, H., Comess, K. M., Shaw, B., The, J., Lima-Fernandes, E., Szewczyk, M. M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2306 · Cited by 224
Self-citationTargeted Protein Degradation by Small Molecules
Bondeson, D. P., & Crews, C. M. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103507 · Cited by 207
Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras
Peeters, K., Van Leemputte, F., Fischer, B., Bonini, B. M., Quezada, H., Tsytlonok, M., Haesen, D., Vanthienen, W., Bernardes, N., Gonzalez-Blas, C. B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01019-z · Cited by 203
BacPROTACs mediate targeted protein degradation in bacteria
Morreale, F. E., Kleine, S., Leodolter, J., Junker, S., Hoi, D. M., Ovchinnikov, S., Okun, A., Kley, J., Kurzbauer, R., Junk, L., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.009 · Cited by 196
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses
Agerer, B., Koblischke, M., Gudipati, V., Montaño-Gutierrez, L. F., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Mühlgrabner, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg6461 · Cited by 172
Production of prone-to-aggregate proteins
Lebendiker, M., & Danieli, T. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.10.044 · Cited by 163
Structure of the Human Autophagy Initiating Kinase ULK1 in Complex with Potent Inhibitors
Lazarus, M. B., Novotny, C. J., & Shokat, K. M. (2015) · ACS Chemical Biology · doi:10.1021/cb500835z · Cited by 154
ROR nuclear receptors: Structures, related diseases, and drug discovery
Zhang, Y., Luo, X.-Y., Wu, D.-H., & Xu, Y. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.120 · Cited by 151
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
Zeng, M., Lu, J., Li, L., Feru, F., Quan, C., Gero, T. W., Ficarro, S. B., Xiong, Y., Ambrogio, C., Paranal, R. M., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.06.017 · Cited by 136
Koenig, P., Lee, C. V., Walters, B. T., Janakiraman, V., Stinson, J., Patapoff, T. W., & Fuh, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613231114 · Cited by 107
Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery
Valkov, E., Sharpe, T., Marsh, M., Greive, S., & Hyvönen, M. (2011) · Topics in Current Chemistry · doi:10.1007/128_2011_265 · Cited by 107
Expanding the scope of electrophiles capable of targeting K-Ras oncogenes
McGregor, L. M., Jenkins, M. L., Kerwin, C., Burke, J. E., & Shokat, K. M. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00271 · Cited by 97
Jackson, T. W., Scheibly, C. M., Polera, M. E., & Belcher, S. M. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c01200 · Cited by 87
AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations
Pacouret, S., Bouzelha, M., Shelke, R., Andres-Mateos, E., Xiao, R., Maurer, A., Mevel, M., Turunen, H., Barungi, T., Penaud-Budloo, M., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.001 · Cited by 69
Skywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function
Fischer, B., Lüthy, K., Paesmans, J., De Koninck, C., Maes, I., Swerts, J., Kuenen, S., Uytterhoeven, V., Verstreken, P., & Versées, W. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3297 · Cited by 62
Methylation-regulated decommissioning of multimeric PP2A complexes
Wu, C.-G., Zheng, A., Jiang, L., Rowse, M., Stanevich, V., Chen, H., Li, Y., Satyshur, K. A., Johnson, B., Gu, T.-J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02405-3 · Cited by 45
Kumar, R., Moche, M., Winblad, B., & Pavlov, P. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-14731-z · Cited by 40
Structural basis for human mitochondrial tRNA maturation
(2024) · doi:10.1038/s41467-024-49132-0 · Cited by 41
Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
de Vries, R. M. J. M., Meijer, F. A., Doveston, R. G., Leijten-van de Gevel, I. A., & Brunsveld, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021287118 · Cited by 38
Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2
Silva-Santisteban, M. C., Westwood, I. M., Boxall, K., Brown, N., Peacock, S., McAndrew, C., Barrie, E., Richards, M., Mirza, A., Oliver, A. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065689 · Cited by 31
“The datasets were collected at beamlines I02, I04 and I24 at the Diamond Light Source (Oxfordshire, UK) and integrated, merged and scaled using the programs MOSFLM (Leslie, 1992) and SCALA from the CCP4 suite (Collaborative Computational Project, Number 4, 1994 [76], see table S1 for data collection and refinement sta…”
MethodInfluentialWatson, V. G., Drake, K. M., Peng, Y., & Napper, A. D. (2013) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2012.495 · Cited by 15
Gunnarsen, K. S., Høydahl, L. S., Neumann, R. S., Bjerregaard-Andersen, K., Nilssen, N. R., Sollid, L. M., Sandlie, I., & Løset, G. Å. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195868 · Cited by 15
Zheng, L., Zhou, B., Yang, Y., Zan, B., Zhong, B., Wu, B., Feng, Y., Liu, Q., & Hong, L. (2024) · Chemical Science · doi:10.1039/d3sc06221j · Cited by 11
(2025) · doi:10.1016/j.molp.2025.09.021 · Cited by 7
Schiedel, M., McArdle, D. J. B., Padalino, G., Chan, A. K. N., Forde-Thomas, J., McDonough, M., Whiteland, H., Beckmann, M., Cookson, R., Hoffmann, K. F., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01321 · Cited by 4
Disruption of CAD Oligomerization by Pathogenic Variants
Del Caño-Ochoa, F., Ramadane-Morchadi, L., Eixerés, L., Moreno-Morcillo, M., Fernández-Leiro, R., & Ramón-Maiques, S. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168832 · Cited by 2
Metadata
- Authors
- Niesen, F. H., Berglund, H., & Vedadi, M.
- Venue
- Nature Protocols
- Published
- 2007-09
- Volume
- 2
- Issue
- 9
- Pages
- 2212-2221
- ISSN
- 1750-2799 (ISSN-L)
- 1754-2189
- OpenAlex
- W2000106654
- Cited by
- 2,408
- References
- 16
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.